Title Phase I/2 Study of PX-866 and Docetaxel in Patients with Solid Tumors (PX-866-002)
Contact DN
Principal Investigator Yujie Zhao, MD
Study Number 175510
Phase2
Summary
The purpose of the phase 2 part of the study is to find out whether PX-866 in combination with docetaxel is better than docetaxel alone at treating patients with locally advanced, recurrent, or metastatic non-small cell lung cancer or squamous cell cancer of the head and neck.
Eligibility See Clinical trials.gov link